Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients
Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Recently, several reports investigating tumor doubling times (TDTs) in lung cancer have demonstrated that lung cancer patients with shorter TDTs have poor prognoses. Although data have shown that the solid component of a tumor is clinically more important, relationships between solid component TDTs and lung cancer prognoses remain unclear.
To ev...
Alternative Titles
Full title
Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_be1f75d86d4b44dbae3854cab333c088
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_be1f75d86d4b44dbae3854cab333c088
Other Identifiers
ISSN
1749-8090
E-ISSN
1749-8090
DOI
10.1186/s13019-019-0879-x
